Cantor Fitzgerald’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.8K Buy
+17,500
New +$44.4K ﹤0.01% 695
2025
Q3
– Sell
-30,000
Closed -$60.9K – 367
2025
Q2
$60.9K Buy
30,000
+10,000
+50% +$17.4K ﹤0.01% 370
2025
Q1
$37.4K Sell
20,000
-5,000
-20% -$12.6K ﹤0.01% 261
2024
Q4
$67.5K Buy
+25,000
New +$78.1K ﹤0.01% 220

Other funds holding ACIU

Cantor Fitzgerald's ACIU Position: Q3 2026 in Review

Cantor Fitzgerald opened a new position in AC Immune (ACIU) in Q3 2026: 17,500 shares worth $45.8K. The stake represents ﹤0.01% of the portfolio and ranks #695 among its holdings. This is a return to the name: Cantor Fitzgerald previously reported a position in ACIU as recently as Q2 2025.

Cantor Fitzgerald first reported a position in ACIU in Q4 2024 and has held it in 4 quarters since. The position peaked at $67.5K in Q4 2024. 40 funds tracked by Wall St. Rank hold ACIU as of Q3 2026.

  • Cantor Fitzgerald held 17,500 shares of AC Immune worth $45.8K as of Q3 2026.
  • AC Immune was a new Cantor Fitzgerald position in Q3 2026.
  • AC Immune made up ﹤0.01% of Cantor Fitzgerald's portfolio in Q3 2026, its #695 holding.
  • Cantor Fitzgerald first reported a position in AC Immune in Q4 2024 and has held it in 4 quarters since.
  • Cantor Fitzgerald's AC Immune position peaked at $67.5K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held AC Immune as of Q3 2026.

Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.